Back to mobile site

H.C. Wainwright Reiterates Buy Rating on Helus Pharma (HELP)

July 22, 2026 6:52 AM EDT Send to a Friend
H.C. Wainwright analyst Patrick R. Trucchio reiterated a Buy rating and $70.00 price target on Helus Pharma (NASDAQ: HELP).The analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login